RE: Operations update for Fortacin/Senstend17 Nov 2020 12:45
Thanks for that Matt.
Usual smoke n mirrors. Submitted on the 16th Nov, approval within 3 months = mid Feb, if not before, yet . By the end of Q1??? Why the fcuk don’t they write “before the end of Q1”. The way they write it, sends mixed messages, ie they don’t know what they are doing let alone what they mean....lol
Then there is the phase II validation study will be completed by the end of 2020, yet the gov website states the end of Jan 2021, which was updated only a couple of weeks ago. Certainly looks like they’ve got the FDA and China syndrome dates mixed up.
The Company believes that China is potentially the single largest market for Senstend....errrr but that’s cos currently China is the only single market with senstend as the products trade name.....jeeeezzz.
.... Anyway, hence the rise today. RPG has more leaks than the Titanic.